Enabling great science, together
At Future Fields, our protein development and manufacturing service focuses on one thing: joint success. Meaning, your success is our success, and we take every step to make sure that your current needs are met and your future needs are taken into account.
De-risking your protein production
Custom batch sizes
- Flexible minimums
- On demand manufacturing
- Expression of difficult, sensitive, and low-expression proteins
- Capacity that does not depend on bioreactor availability
Quality standards that meet your needs
- Protein purity, identity, concentration, activity, stability testing
- Quality management system built on pharma-compliant software
- Can accommodate standards from research use only to pre-clinical compliance
Low production and development costs
- Affordable pricing with custom batch sizes
- Invoicing based on project milestones
- Discounts on new protein targets after first project completion
- No expensive reagents and consumables
Betterment for the planet
- Green-certified lab
- Part of the My Green Lab Ambassador network
- Engaging with local waste management partners
- Donating 1% of revenue to environmental non-profits
- Supporting United Nations Global Compact
What to Expect With Us
Phase 0
Consultation and Project Scoping
Phase 1
Protein Expression
Phase 2
Scale-up of Biomass for Production
Phase 3
Protein Purification
Phase 4
Quality Checks and Assurance
Optimized for Your Research Use or Commercial Needs
Tailored to meet the needs of small-to-medium-sized biopharmaceutical companies and research use only reagent manufacturers, our CDMO offering leverages our proven EntoEngine™ platform to deliver a faster and more affordable solution for the design and production of high-quality proteins.
“Future Fields is advancing a new paradigm for lower-cost protein development and biomanufacturing by harnessing fruit flies. Its EntoEngine platform has already been proven as highly successful at supplying high-quality, recombinant proteins. Scaling up and down for small-batch needs, Future Fields excels at mass-producing proteins more cost-effectively and sustainably than conventional approaches used by other CDMOs.”
- Dr. Mike Brownleader, CEO of Allotap, Co-founder of Zentraxa
Powered by people, fly by design
Future Fields' EntoEngine: Genetically engineered Drosophila melanogaster
Every efficiency achieved through our biotechnology is shared with you–meaning you can enjoy all the benefits of quality, high-performance, and investment into sustainability, all without the high price tag. With cost-effective, custom batch sizes suited for research use only up to pre-clinical trials, we start you off on the right foot.
Our modular, insect-based production system is bioreactor-free. Reaching grams to kilograms of protein production per day, with continous production and no need to wait for bioreactor availability and cleaning, our system delivers you reliable timely output at mass levels of scale.
Once we develop your protein, you're set for life – expression stocks containing your protein of interest are maintained throughout generations, as opposed to CHO or HEK cells. Our expedited clonal selection and continuous production system leads to faster manufacturing cycles – all resulting in a predictable, time-saving production process as you scale.